Showing 1411-1420 of 1746 results for "".
Comfort of Dailies Total1® for Astigmatism in Symptomatic Habitual Reusable Toric Lens Wearers
https://modernod.com/articles/2024-nov-dec-insert/comfort-of-dailies-total1-for-astigmatism-in-symptomatic-habitual-reusable-toric-lens-wearersThe Future of Eye Care for Children
https://modernod.com/topics/health-policy/the-future-of-eye-care-for-children/38825/Part one of this multi-part series analyzes proposed legislation to support early eye care intervention in children.Expanding the Corneal Topical Therapy Arsenal
https://modernod.com/topics/corneaanterior-segment/expanding-the-corneal-topical-therapy-arsenal/38807/Three emerging medications to add to your toolkit, each for a different corneal indication.Ophthalmic Presentations of Pituitary Adenoma
https://modernod.com/mod-issues/2020-nov-dec/ophthalmic-presentations-of-pituitary-adenoma/39115/The ocular examination can aid diagnosis and help guide treatment.A Review of Pharmacologic Treatments for Presbyopia
https://modernod.com/topics/presbyopia/a-review-of-pharmacologic-treatments-for-presbyopia/39027/With several therapies on the market, understanding their differences is the key to optimizing clinical decision making.Myopia: a Global Epidemic
https://modernod.com/mod-issues/2019-nov-dec/myopia-a-global-epidemic/39091/An overview of the problem and efforts to address it.- OD-OS Achieves Revocation of Iridex MicroPulse Patenthttps://modernod.com/news/od-os-achieves-revocation-of-iridex-micropulse-patent/2480020/OD-OS has achieved the revocation of the MicroPulse Patent (Patent no EP1856774) by Iridex Corporation in oral proceedings at the European Patent office held last Friday in Munich, Germany according to an OD-OS news release. With its successful opposition, OD-OS has cleared the path to man
- OD-OD Introduces a New Learning App for Retinal Laser Treatmenthttps://modernod.com/news/od-od-introduces-a-new-learning-app-for-retinal-laser-treatment/2479529/To address growing demand for interactive learning technology, OD-OS has developed a tool for implementing a better approach to retinal laser treatment: The Navigate App. Navigate is a free, interactive tool designed to support residents and team education—both onsite and online. The platf
- I-MED Pharma Partners With Quidel to Introduce I-Lid ’N Lash, I-Relief, and SMTube to the US Markethttps://modernod.com/news/i-med-pharma-partners-with-quidel-to-introduce-i-lid-n-lash-i-relief-and-smtube-to-the-us-market/2479777/I-MED Pharma, a company specializing in dry eye diagnosis and management, announced the signing of an exclusive distribution agreement with Quidel Corporation, a leading provider of rapid diagnostic testing solutions, cellular-based virology assays, and molecular diagnostic systems, for I-MED Pha
- OD-OS Introduces the Navilas expertLibrary Forum for Retina Specialistshttps://modernod.com/news/od-os-introduces-the-navilas-expertlibrary-forum-for-retina-specialists/2480093/OD-OS has introduced a new forum for retina specialists – the Navilas expertLibrary. The Navilas expertLibrary is an exclusive forum where leading retinal physicians share their day-to-day experience with this novel navigated retinal laser technology, according to OD-OS. Interested parties